RESUMEN
BackgroundCOVID-19 infection has revealed a considerable number of extra-pulmonary manifestations, especially rheumatological. The detection of these manifestations, which herald the infection, is of great value in the early diagnosis of the disease, especially in health care workers (HCWs) who are at considerable risk of infection. Although myalgia is a common clinical feature of COVID-19, other musculoskeletal disorders (MSDs) have been rarely described.ObjectivesTo describe MSDs during SARS-COV2 infection in HCWs.MethodsProspective descriptive study conducted at the department of occupational pathology and fitness for work of Charles Nicolle Hospital in Tunis, having included the HCWs affected by COVID-19 during the period from 01 September 2020 to 28 February 2021. Data collection was carried out by regular telephone follow-up during the containment period using a pre-established form.ResultsDuring the study period, 656 HCWs were infected with SARS COV 2, of whom 134 (20.4%) had at least one musculoskeletal event. The mean age was 42±9 years with a sex ratio (M/F) of 0.2. The most represented occupational category was nurses (33.6%) followed by health technicians (23.1%). The median professional length of service was 12 [7;20] years. The presence of comorbidity was noted in 58.2% of HCWs. A pre-existing osteoarticular disease was found in 8.2% of cases. Obesity was noted in 25.4% of the population. Active smoking was reported by 14.3% of respondents. A known vitamin D deficiency was noted in 16.5% of patients. Spinal pain was the most reported MSD, present in 87.3% of cases. Low back pain was the most frequent spinal pain (56.7%) followed by back pain (37.4%) and neck pain (5.9%). MSDs of the lower limbs were found in 12.7% of patients. They were represented by gonalgia in 11.9% of cases, ankle pain in 5.2% of cases and hip pain in 4.3% of cases. MSDs of the upper limbs were described by 7.5% of the patients, 92.5% of whom presented with shoulder pain. The median duration of MSDs during COVID-19 was 5 [3;8] days. These manifestations were persistent on return to work in 21.1% of cases.ConclusionKnowledge of the frequency and consequences of musculoskeletal manifestations related to COVID-19 infection is of great importance, particularly in HCWs, in order to optimise management and ensure a rapid return to work.REFERENCES:NIL.Acknowledgements:NIL.Disclosure of InterestsNone Declared.
RESUMEN
BackgroundIn Tunisia, during the last decade, the number of MSDs declared as compensable occupational diseases has been increasing. So, what is the impact of the COVID-19 pandemic on the MSD reporting rate.ObjectivesTo describe the socio-professional characteristics of workers with musculoskeletal disorders (MSDs) and to determine the reporting rate of MSDs as occupational diseases.MethodsA descriptive cross-sectional study among workers with work-related MSDs who consulted the occupational medicine department of the Charles Nicolle Hospital for medical advice between January 2021 and September 2022.ResultsA total of 109 workers with MSDs were included in this study. The workers were 64.2% female. The average age was 46 ± [21-61 years]. The sectors most prone to MSDs were the health sector (27.5%), food processing (16.5%) and textiles (15.6%). The workers reported MSDs of the upper limb in 31.2%, MSDs of the lower limb in 33.9% and of the spine in 69.7%. These MSDs reported included 5/13 cases of rotator cuff tendinopathy, 6/13 cases of carpal tunnel syndrome, one case of achilles tendonitis and one case of Dequervain's tenosynovitis.ConclusionDuring the COVID-19 pandemic, the reporting of MSDs as occupational diseases has declined considerably. This decline can be explained by the difficult access to hospital facilities.References[1]https://www.emro.who.int/emhj-volume-23-2017/volume-23-issue-11/prevalence-et-determinants-des-troubles-musculo-squelettiques-des-membres-superieurs-chez-les-artisans-tunisiens.html.[2]http://medecinetravail.canalblog.com/archives/2011/10/04/22196851.htmlAcknowledgements:NIL.Disclosure of InterestsNone Declared.
RESUMEN
Declaration de liens d'interets: Les auteurs declarent ne pas avoir de liens d'interets.Copyright © 2023
RESUMEN
Declaration de liens d'interets: Les auteurs declarent ne pas avoir de liens d'interets.Copyright © 2023
RESUMEN
Declaration de liens d'interets: Les auteurs declarent ne pas avoir de liens d'interets.Copyright © 2023
RESUMEN
COVID-19 vaccination is one of the most effective ways to prevent the spread of SARS-CoV2. However,these vaccines are not devoid of adverse effects requiring post-vaccination follow-up. Aim(s): Determine the frequency of adverse events(AEs)of an anti-COVID-19 messenger RNA vaccine (mRNA) collected among health care workers(HCW) at Charles Nicolle Hospital in Tunis. Method(s): Descriptive cross-sectional study carried out in September 2021, involving the HCW of the Charles Nicolle hospital in Tunis who had received the first dose of an mRNA anti-COVID 19 vaccine during a mobile vaccination campaign in the workplace. The data collection was carried out using a pre-established questionnaire containing the adverse vaccine reactions defined by the Tunisian Ministry of Health technical sheets. Result(s): The study population was composed of 139 HCW. Post-vaccine AEs were reported in 78% of cases. A predominance of women was noticed(78%). The age group most affected was between 40 and 45 years old. The most common AEs were injection site pain in 65% of cases, fever in 30% of cases, headache in 15% of cases and myalgia in 14% of cases. In addition, four cases of dizziness, two cases of generalized pruritus and one case of lymphadenopathy and acute peripheral facial paralysis were reported. The time to onset of AEs ranged from the same day to three days. The average duration of these AEs ranged from one to seven days. Five percent of our population took time off work which variated from one to three days. Conclusion(s): The occurrence of AEs following vaccination with an mRNA vaccine should not destabilize the promotion of vaccination in the workplace. However, close post-vaccination surveillance is necessary to ensure good occupational activity in the care setting.
RESUMEN
Declaration de liens d'interets: Les auteurs declarent ne pas avoir de liens d'interets. Copyright © 2022
RESUMEN
Introduction: La pandemie COVID-19 a eu d'importantes repercussions sur la sante physique et psychologique des personnes infectees par le virus du SARS-CoV-2. Neanmoins, cet impact s'est avere encore plus significatif chez le personnel de sante (PS) place en premiere ligne dans la gestion de cette crise sanitaire. L'objectif de notre etude etait d'evaluer la qualite de vie du PS un an apres une infection par le SARS-CoV-2. Methodes: Etude transversale ayant interesse le PS de l'hopital Charles Nicolle, pour lequel un diagnostic de COVID-19 avait ete pose durant la periode allant du 1er au 30 juin 2021. Les donnees collectees portaient sur les caracteristiques sociodemographiques et professionnelles. La qualite de vie des PS etait evaluee un an apres l'infection, en utilisant le questionnaire SF12 dans ses deux dimensions physique et mentale. Resultats: La population d'etude comportait 170 PS atteints de COVID-19. Le taux de reponse etait de 67 %. L'age moyen etait de 43,2 +/- 10 ans avec un sex-ratio (H/F) de 0,6. La categorie professionnelle la plus representee etait celle des infirmiers dans 46,4 % des cas et des ouvriers dans 31,2 % des cas. A un an en post-infection, la qualite de vie physique (PCS) et mentale (MCS) etait satisfaisante avec un score SF12 moyen de 61,9 %, PCS moyen a 60,5 % et MCS moyen a 62,7 %. Une difference statistiquement significative etait notee avec la categorie professionnelle (SF12 moyen : p < 10-3, PCS : p = 0,39, MCS : p < 10-3, IC = 95 %). Aucune difference statistiquement significative n'a ete trouvee selon le sexe. Conclusion(s): Notre etude suggere que la COVID-19 n'a pas affecte la qualite de vie des professionnels de sante un an apres l'infection. Toutefois, un suivi regulier reste necessaire. Copyright © 2022